tected in two forms, either with or without the transmembrane domain, suggesting occurrence of post-translational cleavage to produce a soluble enzyme. In addition the furin active site has differential accessibility in the granular layer of the epidermis relative to the basal layer, whereas antibodies to the transmembrane domain stain both layers. These findings suggest that furin has access to different types of substrates in granu- a site between the amino terminus and the first filaggrin repeat. This
Introduction
The sequential differentiation of keratinocytes in the epidermis is a complex, highly regulated series of events that results in the formation of the anucleate cornified cells of the stratum corneum from the relatively undifferentiated cells of the basal layer. This differentiation process is calcium dependent and requires extensive and tightly controlled changes in both protein expression and enzymatic activities resulting in characteristic morphological changes of the cells. Proteolytic processing is an important mechanism for many of these events, including signaling, proprotein activation, structural remodeling and desquamation. A number of different proteases have been iden-
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tified that play a role in epidermal differentiation. These include calpain I (1), cathepsins C (2, 3), B, H and L (4), profilaggrin endopeptidase (PEP1) (5) , the stratum corneum chymotryptic-like protease (SCCP) and the stratum corneum thiol protease (SCTP) (6) . The importance of proteases in the epidermis is highlighted by the finding that null mutations of cathepsin C result in palmoplantar keratoderma disorders, specifically Haim-Munk and Papillon-Lefevre syndromes (2, 7, 8) .
A protease family that has been implicated in processing and differentiation in a number of tissues is the Proprotein Convertase (PC) family. This is a family of Ca 2π -dependent serine proteases related to bacterial subtilisin (for reviews see [9] [10] [11] [12] . To date 7 family members have been iden-tified; furin (also known as PACE), PC2, PC1/3, PACE4, PC4, PC5/6 and PC7/8/LPC. Of these furin, PACE4, PC5/6 and PC7/8 are widely expressed whereas PC2 and PC1/3 are limited to neuro-endocrine tissues and PC4 is restricted to the testis, suggesting both generalized and tissue-specific patterns of expression and function. The PC enzymes recognize basic motifs, cleaving after paired basic residues (PC2 and PC1/3) or after a canonical RX(R/K)R motif (furin and PACE4); in some substrates a P6 Arg can substitute for the Arg at the P4 position (13) . Furin has been shown to process a wide variety of substrates including receptors, growth factors, hormones, plasma proteins, matrix metalloproteinases and extracellular matrix components. In addition PC family members are also involved in the processing of exogenous proteins such as some viral envelope glycoproteins and bacterial endotoxins (12) .
Several proteins relevant to keratinocyte development have been shown to be substrates for PC processing or contain potential PC cleavage sites. These include receptors such as Notch-1 (14, 15) , matrix components such as collagen XVII (BP180) (16) , matrix metalloproteinases, desmosomal components such as desmoplakin-1 and desmoglein, integrins including integrins a3 and a6 (17) and structural proteins such as profilaggrin.
Although PCs have diverse substrates and play a role in differentiation in some systems there has been no systematic study of PC expression in epidermis (2) . We therefore investigated the expression and distribution of the members of the PC family in epidermis and examined the processing of several potential substrates.
In this study, 4 members of the PC family (furin, PACE4, PC5/6 and PC7/8) were detected in epidermis. Furin and PC7/8 were detected in distinct, although overlapping, patterns within the epidermis. In addition the active site of furin showed differential accessibility during differentiation. Inhibition of the PC family in culture inhibited the processing of Notch-1 and in vitro results characterized a furin/PACE4 processing site in the amino terminus of profilaggrin. The specific localization pattern, calcium dependence, and identification of possible substrates are consistent with a role for PCs in multiple events during epidermal differentiation.
Methods

Keratinocyte culture
Human foreskin keratinocytes were cultured using the methods described by Fleckman et al. (18) , a modification of the Rheinwald-Green system. Cells were harvested for RNA or protein at either 194 ∂60-70% of confluence, at 100% confluence or several days post-confluence.
Detection of proprotein convertase expression in skin using degenerate primers
The sequences of the known human PC members (furin, PACE4, PC1, PC2, PC5/6, PC7/8) were obtained from Genbank using the ENTREZ server. The sequences were multiply aligned using ClustalW (19, 20) and a highly conserved region of the catalytic domain was identified to which degenerate primers were designed. The sense primer (5ø-CA(C/T) GG(C/G) AC(A/T/G/C) (A/C) G(A/T/G/ C) TGTGC (A/T/G) GG-3ø) was based on the sequence R 194 HGTRCAG 201 in furin which contains the active site arginine (R 194 ). This sequence is 100% conserved across the known human members of the PC family and highly conserved in other species. The antisense primer (5ø-GG (T/G) CCC CAG CT (T/G) (C/G) (A/C) (A/G) CTG TA-3ø) was based on the sequence I 249 YSASWG 255 which is also highly conserved across the family, although in PC7/8 the alanine (A 252 ) is replaced by a cysteine. RT-PCR using these primers would amplify a 187 bp segment from each PC that could be distinguished on the basis of its nucleotide sequence.
Total RNA was isolated from 5-day post-confluent cultured human keratinocytes using the Trizol reagent (Life Technologies, Gaithersburg, MA, USA) and the manufacturer's protocol. After DNase I treatment the total RNA was reverse transcribed using the Superscript II RT system (Life Technologies) and the resulting cDNA was PCR amplified (40 cycles at 95 aeC for 30 s; 60 aeC for 1 min; 72 aeC for 1 min) using Taq plus Taq extender (Promega, Madison, WI, USA). The resulting 187 bp product was gel purified and TA cloned into the pCR3.1 vector (Invitrogen, Carlsbad, CA, USA).
Northern analysis
Total RNA was isolated from human foreskin keratinocytes according to the method of Chomczynski & Sacchi (21) , fractionated on glyoxal gels, transferred to Genescreen Plus (Du Pont NEN, Boston, MA, USA) by capillary blotting according to manufacturer's recommendation, and hybridized with radiolabeled cDNA probes specific for the coding region of different members of the PC family (22, 23) . The blots were subsequently hybridized with a GAPDH probe and the ratio between furin and GAPDH determined by Phosphorimager (Molecular Dynamics, Sunnydale, CA, USA).
RT-PCR analysis of PC5/6 and PC7/8
Oligoprimers specific for PC5/6 and PC7/8/LPC were made according to published sequences (Genbank acc. NM-004716). For PC5/6 the sense primer used comprised nucleotides 962-982 (5ø-TCA GCA GCA CTG CAG AAA GC-3ø) and the antisense primer, nucleotides 1409-1429 (5ø-TGG GGT CTT CAA CTC GGC TA-3ø), giving a 447 bp product. For PC7/8 the sense primer 163-183 (5ø-GCT GGT AGG CTG TTT CAC CG-3ø) and 667-647 (5ø-GGA TTG CTG CCA GAG AAG TC-3ø) were used giving a 504 bp product. Reverse transcription was performed on the total RNA using the Superscript II kit (Life Technologies). PCR analysis was performed using 32 cycles of 94 aeC, 1 min; 50 aeC, 45 s; 72 aeC, 1 min using Taq polymerase (Promega). PCR products were analyzed on a 1% agarose gel and their identity confirmed by sequence analysis.
PC protein expression in epidermis and keratinocytes
Protein from foreskin epidermis and cultured human keratinocytes was extracted using a modified RIPA buffer (50mM HEPES, pH 7.5, 150 mM NaCl, 50 mM NaF, 1% NP-40, 0.5% deoxycholate, 1 mM sodium vanadate, 1 mM nitrophenylphosphate, 5 mM benzamidine, 2 mM PMSF, 10 mg/ml aprotonin, 1¿ complete protease inhibitor (EDTA-free, Boehringer)) (24) . The extracted proteins were separated on 7.5-12% SDS-PAGE gels and blotted onto nitrocellulose for western immunoblot detection using specific antibodies and ECL. Furin was detected using a polyclonal antibody directed against the C-terminal tail (cfur) (a gift from Ruth Hogue Angeletti, New York University, USA) and monoclonal antibodies raised against catalytic domain (MON148) or cysteine-rich domain (MON152) epitopes (Alexis Biochemicals, San Diego, CA, USA). PC7/8 was detected using polyclonal antibodies directed against the catalytic and C-terminal domains (gift from Dr W. J. M. Van de Ven, Katholieke Universiteit Leuven, Belgium). PACE4 was detected using an antibody directed to the pro and catalytic domains (Alexis Biochemicals).
Localization of furin in epidermis
Immunofluorescence was performed on methanol fixed frozen or paraffin embedded methyl-Carnoy's fixed human epidermis. Carnoy's fixed tissues were first rehydrated and from then on all sections were treated the same. Antigen unmasking was performed on selected sections by incubation with 195 0.1% trypsin for a variable length of time (usually 3 min). After preblocking the sections with serum specific for the secondary antibodies used, the sections were incubated with the primary antibodies in TBS containing 1% BSA overnight at 4 aeC. The primary antibodies were detected with either FITC-conjugated secondary antibodies (Vector, Eugene, OR, USA) or biotin-conjugated secondary antibodies followed by streptavidin-conjugated Texas Red (Vector). DNA was stained with 4ø,6-diamidino-2-phenylindole dihydrochloride (DAPI, 0.001%). Sections were mounted in Prolong A mounting medium (Molecular Probes, Eugene, OR, USA). Images were obtained using a CCD camera attached to an epifluorescence Nikon SA microphot microscope.
Inhibition of proprotein convertases in cultured keratinocytes
Mouse epidermal keratinocytes were cultured to confluence as described previously (25) . The PC inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (Bachem, Torrence, CA, USA) (26) was added to the medium at feeding. Cells shed into the medium were collected by centrifugation and extracted first in RIPA buffer (24) and the pellet was subsequently re-extracted in 8.8 M urea-Tris buffer (27) . Equal amounts of protein were run on SDS-PAGE gels, blotted, probed with specific antibodies, including Notch-1 (a gift from L. Milner, Fred Hutchinson Cancer Research Center, Seattle, WA, USA) and visualized by ECL.
In vitro cleavage of profilaggrin by furin and PACE4
Preparation of furin and PACE4 enzymes. Transient transfectants of COS-1 or 293T cells with furin, mutant furin, and PACE4 expression constructs and with the control vector were performed as described elsewhere (22) . Conditioned media from cells expressing soluble furin (furin), mutant soluble furin with the active site altered from serine to alanine (furin-SA), PACE4, and pMT3 (a control vector) (22, 23, 28) were harvested and concentrated 10-fold using Centricon 10 (Amicon, Beverly, MA, USA) in 0.2 M sodium acetate pH 5.5. The concentrated media were stored in aliquots at ª80 aeC until use.
Construction and expression of the profilaggrin substrate
The cDNA expression construct used for these studies (referred to as pFLAG467proF) encodes the amino-terminal 467 amino acids of human profilaggrin, including the entire amino-terminal A π B domains, plus the truncated filaggrin sequence. Preparation of the construct is described elsewhere (27) . The construct encodes the 8 amino acid FLAG epitope at its amino-terminus. The profilaggrin cDNA construct was cloned into pcDNA3 (Invitrogen) for in vitro expression studies. COS-7 cells were transiently transfected using LipofectAMINE (Life Technologies) with 5.5 mg of the profilaggrin cDNA constructs. Cells were usually harvested 48 h after transfection and lysates prepared in 0.25 M Tris/HCl, pH 7.8, using three freeze/thaw cycles in dry ice-ethanol and 37 aeC water baths. Solubilized cell extracts were clarified by centrifugation at 12,000 r.p.m. for 10 min and stored frozen in aliquots until use.
Site-directed in vitro mutagenesis
Site directed mutagenesis on double-stranded pFLAG467proF DNA was performed using the method based on the QuikChange mutagenesis kit (Stratagene, LaJolla, CA, USA) to render a nonconservative mutation, either at P1, P2, or P4 of the cleavage site, from Arg/Lys to Ala. The three mutagenic oligonucleotide primers (Life Technologies) were as follows (5ø to 3ø) (mutated bases are underlined, and the amino acid changes produced at the cleavage site are shown in brackets):
P1/Ala, GGACAAGAAAGCGTGCGGGATCCA GAGTTAGC (RKRA); P2/Ala, GGACAAGAAAGGCTAGGGGATCCA GAGTTAGC (RKAR); P4/Ala, GGAGTCCAGGA CAGCAAAGCGTAGGGG (AKRR). The altered PC cleavage sites were confirmed by sequencing the mutated constructs.
Proprotein convertase cleavage assay and immunoblotting procedure
COS-7 cell extracts containing the substrate were incubated with conditioned or mock medium (enzyme or control prep) at 37 aeC for 16 h in a final volume of 50 ml of 0.1 M HEPES buffer (pH 7.0), 1 mM b-mercaptoethanol, and 5 mM CaCl 2 . The reaction was terminated by the addition of SDS-PAGE sample buffer and boiled before loading onto a 12% or 12-15% gradient SDS-polyacrylamide gel. The gel was electroblotted to nitrocellulose and the amino-terminal domain of profilaggrin identified using the polyclonal anti-B1-peptide antibody described previously (specific for the B domain) (27) . Medullo blastoma cell line (UW) was used as a positive control for furin/PACE expression. RNA was fractionated on a 1% glyoxal gel, blotted, and hybridized with DNA probes specific for furin/PACE, PACE4, and profilaggrin. The blots were subsequently hybridized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to normalize the amount of RNA. Molecular weight markers are designated on the left. Both subconfluent and confluent (profilaggrin expressing) keratinocytes expressed a 5 kb furin message and a similar sized PACE4 transcript. The furin message was increased 3-fold in confluent vs subconfluent cells. (B) RT-PCR analysis of total RNA from foreskin epidermis (F) and from subconfluent (S), confluent (C), and postconfluent (P) keratinocytes cultures. Primers specific for PC5/6, PC8, and actin were used. Both cells and tissue had detectable levels of PC5/6 and PC7/8.
Results
Members of the proprotein convertase family are expressed in human keratinocytes
To determine if human epidermal keratinocytes express members of the PC family we analyzed mRNA expression using degenerate primers directed towards the active site of the PC family. Cloning and sequencing of multiple products resulted in identification of furin, PACE4, PC5/6 and PC7/8. In order to confirm this expression pattern we used Northern blot and RT-PCR analysis of epidermal and cultured human keratinocyte RNA. Northern analysis of total RNA from human keratinocytes at subconfluence and confluence using cDNA probes specific to human furin/PACE and PACE4 shows hybridization signals with the molecular size of approximately 5 kb (Fig. 1A) ; similar to the size of these mRNAs in other cells and tissues (12) . Quantitative Phosphorimager analysis of the level of furin/PACE expression relative to GAPDH indicates that the level increased approximately 3-fold upon confluence. GAPDH expression levels are unchanged in pre vs postconfluent cells (29) . Similar results were obtained with PACE4 expression (Fig. 1A) . As a control for changes in keratinocyte gene expression with confluence, the level of human profilaggrin mRNA was evaluated. Profilaggrin expression increased dramatically in the confluent cultures (Fig. 1A) , consistent with previous results (29) . In addition, mRNAs for PC5/6 and PC7/8/LPC were detected by RT-PCR amplification using specific primers (Fig. 1B) both in cultured keratinocytes and foreskin epidermis; the identity of these products was confirmed by sequencing. Probes corresponding to PC1/PC3, PC2, and PC4 were tested by Northern blotting but did not hybridize to keratinocyte RNA under the conditions used, nor were they detected in RT-PCR experiments (data not shown), in agreement with previous evidence suggesting that these PC family members are specific to other cell 
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types or tissues (12) . Thus, we have evidence for expression of four members of the PC family in epidermal keratinocytes.
Proprotein convertase protein expression in epidermis and keratinocytes
Antibodies to the catalytic domain and cytoplasmic domains of both furin and PC7/8 were used to further examine expression and localization of these proteins in epidermis (Figs 2, 3 & 4) .
The 97 kDa mature furin was detected in foreskin epidermal extracts and in subconfluent and postconfluent keratinocytes (Fig. 2A) . The 97 kDa protein was recognized by antibodies to the C-terminal cytoplasmic domain (c-fur), catalytic domain (MON148) and the cys-rich domain (MON152) indicating that it corresponds to the mature enzyme after proteolytic removal of the prepro domain. This band corresponds to the size of a furin expressed in COS cells via a cDNA con- struct. An additional 70-75 kDa band was observed in epidermis and keratinocytes that reacted with antibodies to the catalytic domain (MON148) and cys-rich domain (MON152), but not the Cterminal cytoplasmic domain (c-fur). This band is slightly smaller than soluble furin produced from a construct lacking the transmembrane and C-terminal domains, indicating cleavage and removal of the transmembrane domain in the tissue. A larger band (∂120 kDa), possibly corresponding to the proenzyme, was detected in keratinocytes but not in foreskin epidermal extracts. The specificity and identity of the bands recognized by the antibodies was confirmed by stripping representative blots and reprobing with an alternate antibody (data not shown).
Three bands (96 kDa, 75 kDa and 70 kDa) positive for PACE4 were detected on western blots in sub-and post-confluent keratinocyte extracts (Fig.  2C ). PC7/8 protein was also detected in pre-and post-confluent keratinocytes (Fig. 2D) . The active form at ∂75 kDa was seen in both pre-and postconfluent cell extracts with both antibodies.
Localization of proprotein convertases in epidermis
Furin staining was detected by immunofluorescent localization within the epidermis. The antibody to the cytoplasmic domain (c-fur) showed strong staining in the basal and granular layers with less staining in the spinous layers (Fig. 3A) . In contrast the antibody against the active site (MON148) showed the greatest concentration of staining in the granular layer (MON148; Fig. 3B ), with less staining in the lower layers of the epidermis. The staining was strongly cytoplasmic. In the granular layer the staining pattern for the cytoplasmic domain (c-fur) and catalytic domain (MON148) were not completely correlated (Fig. 3C) . Areas of yel- low in the granular layer indicate where the red MON148 staining and green c-fur staining are colocalized (merged). There are, however, significant areas where the two antibodies are not superimposed (red and green staining in the granular layer). Strong furin staining was also seen in the glandular structures of the dermis (not shown).
Antibodies specific for PC7/8 showed patchy staining throughout the epidermis (Fig. 4) . This distribution was similar with both the antibody directed against the C-terminal cytoplasmic domain (KP1) (Fig. 4A) and that directed against the catalytic domain (MP1) (Fig. 4B) . Figure 5 . Inhibition of Notch-1 processing in mouse keratinocytes by decanocyl-RVKR-CMK. Mouse keratinocytes were treated with the inhibitor or vehicle for 4 days. Cell extracts were separated on a 7.5-15% SDS-PAGE gel, blotted onto nitrocellulose and probed with a monoclonal anti-Notch-1 antibody directed to an epitope in the intracellular C-terminal domain using the ECL system. The 120 kDa active Notch-1 amino-terminal domain (*) is detected in the pretreated cultures (day 2) as well as in the day 4 cultures without the PC inhibitor but is significantly reduced in cultures treated with 100 mM and 250 mM of the inhibitor. The position of molecular weight standards is shown on the left. The Notch-1 pro-form is not detected due to its poor reactivity with the antibody (Milner, personal communication) .
Identification of potential PC substrates in epidermis
Two potential substrates, Notch-1 and profilaggrin, relevant in epidermal differentiation, were investigated using either in vivo or in vitro approaches.
Inhibition of Notch-1 processing by inhibition of proprotein convertase processing in culture
Notch-1 is a cell-surface receptor involved in cell fate determination and patterning. Processing of Notch-1 by furin at an RXRR site in the carboxy terminus during transport to the plasma membrane is required to produce the functional receptor (14, 30) . A cell permeable PC inhibitor (decanoyl-RVKR-CMK) (26) was added to mouse keratinocyte cultures to test the role of furin on Notch-1 processing in these cells. Inhibition of the processing of Notch-1 from the precursor form (220 kDa) to the functional 120 kDa form (Fig. 5) was seen with dramatic reduction of the 120 kDa form using both 100 and 250 mM of the inhibitor. The inhibitor did not exhibit toxic effects on the cells at these concentrations.
Furin and PACE4 specifically cleave the amino terminus of profilaggrin
Profilaggrin is a large (Ͼ400 kDa) protein, comprised of multiple filaggrin domains flanked by unique N and C-termini, that is expressed in the granular layer of the epidermis (reviewed in 31). Normal keratinocyte culture systems can be induced to produce profilaggrin (18, 29, 32) but do not fully process it into filaggrin and the aminoterminal fragment. Therefore, to study potential PC processing of profilaggrin at the predicted sequence (R 288 TRKRR 293 ) at the junction of the amino terminus and the filaggrin domains, an in vitro system was used. Extracts obtained from COS-7 cells transfected with the N-terminal profilaggrin expression construct, pFLAG467proF, were used to mimic profilaggrin; profilaggrin itself is insoluble in aqueous buffers suitable for enzyme assays and therefore could not be used in these assays. Media conditioned by COS-1 or 293T cells transfected with expression constructs encoding either a soluble form of furin, its inactive mutant derivative (furin-SA), or PACE4 were sources of the enzymes. Cleavage of the substrate was de- Figure 6 . Cleavage of profilaggrin (pFLAG467proF) by furin and PACE4. Extracts of COS-7 cells transfected with the pFLAG467proF were incubated with conditioned media containing expressed enzyme. The products were analyzed using antibody specific for the B domain of the profilaggrin aminoterminus. The position of uncleaved product is shown by the arrow. Note that a cleaved product (approx. 37 kDa*) is detected in the samples containing furin (strong) and PACE4 (weak), but not those containing an inactive mutant (furin-SA) or mock transfected media or the unreacted substrate (hABfg). The endogenous profilaggrin N-terminus (32 kDa) is visible in the foreskin extract (arrowhead). Molecular weight markers are indicated on the left. A diagram of the FLAG467proF construct is shown to illustrate the A and B domains and the position of the predicted cleavage site.
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tected by the appearance of the processed fragment on western blots using antibodies specific for the B domain of the profilaggrin N-terminus. The antibody specific for the amino-terminus reacts with both the amino-terminal-profilaggrin substrate and the expected cleavage product (Fig. 6) , whereas the antibody specific for filaggrin reacts only with the amino-terminal-profilaggrin substrate and not with the cleaved product (data not shown). As shown in Fig. 6 , only treatment of the profilaggrin substrate with the soluble form of furin or with PACE4 but not with the mutant furin (furin-SA) resulted in the appearance of a new band representing the proteolytic cleavage product with a size of approximately 37 kDa. This cleavage is Ca 2π -dependent and can be inhibited with EDTA (data not shown). Control substrate (von Willebrand factor or CPA-PACE) was used to verify that the enzyme preparations functioned as expected (data not shown).
In order to confirm the specific site of PC cleavage, the proposed cleavage site (R 288 TRKRR 293 ) was mutated to see if specific processing could be affected. Fig. 7 shows that substitution at either the P1 position (to RKRA) or the P4 position (to AKRR) virtually abolished the cleavage which produces the 37 kDa product in the normal construct, whereas the alteration of the P2 position (to RKAR) had little effect on the cleavage. The results demonstrated that the predicted paired amino acid sequence is required as the primary target site Figure 7 . Effect of mutation at residues P1, P2, and P4 of the putative profilaggrin cleavage site. COS-7 cells were transfected with the profilaggrin expression construct carrying either the parental (RKRR) or one of the mutant cleavage sites (RKRA, RKAR, AKRR) and the extracts were treated with conditioned media containing mock media (lane 1) or soluble furin (lane 2). The 37 kDa cleaved product is visible in the furin cleaved-parental construct and the RKAR mutant and was identified using the antibody specific for the profilaggrin B-domain (*). The normal 37 kDa cleavage product is absent from the RKRA and AKRR mutants although a secondary cleavage product at 40 kDa is seen (arrowhead). Molecular weights are indicated on the left. Lane F is human foreskin extract run as a control on the same gel showing the 32 kDa endogenous cleavage product.
for furin/PACE cleavage in vitro. Interestingly, mutagenesis of each of the critical residues (P1, P4) yielded another cleaved product migrating at about 40 kDa. This product could be either an intermediate of a sequential cleavage or a product resulting from an alternative secondary site, possibly the sequence GSRHPR present at residues 331-336.
Discussion
The dramatic remodeling of cytoplasm and cell membrane that occurs at the transition of the granular and cornified layers to form the protective skin surface requires multiple proteolytic events, breakdown of nucleic acids and membranebounded cellular organelles, and restructuring of the keratin cytoskeleton and plasma membrane. The changes in keratinocytes during the basal to spinous layer transition are not as dramatic morphologically yet regulate the balance between proliferation and withdrawal from the cell cycle and differentiation. The results presented here show that members of the PC family are likely to play a role in these events, consistent with their involvement in differentiation of gut epithelia and other tissues (33) .
We have shown the expression in epidermis of four PC family members; furin, PACE4, PC5/6 and PC7/8 at the mRNA level and detected protein for three of these proteases. Furin, in particular, is detected in two forms -the mature 97 kDa form and a smaller 75 kDa form that lacks reactivity with the c-fur antibody specific for the C-terminus. Based on size and antibody reactivity, the 75 kDa form is expected to lack the transmembrane domain. This size difference may be associated with the change in the accessibility of furin in the different layers of the skin shown by immunocytochemistry using antibodies directed to specific epitopes. The cytoplasmic C-terminal domain is detected in both the basal (less differentiated) layer and the granular layer whereas the catalytic domain is most readily detected in the granular layer where cells are preparing to undergo terminal differentiation. This implies that the catalytic domain is more accessible to the antibody in the granular cells. As the cells of the granular layer are undergoing significant remodeling, including the dissolution of membranous organelles and the remodeling of the golgi/transgolgi apparatus into lamellar granules (34) (35) (36) , it is likely that there is some rearrangement of the normal contents of these organelles, including the normally trans-golgi resident furin, which would allow it access to a wider range of substrates in these cells.
These results suggest that furin might play 201 multiple roles in epidermal differentiation depending on the cell layer. Thus in the basal layer it would be expected to be involved in processing of secreted substrates including collagen XVII, integrins a3 and a6, and Notch, which mature via the golgi-transgolgi route. Our studies clearly show that inhibition of furin (and other PCs) in keratinocytes blocked the processing of Notch-1, a cell surface receptor that has been shown to be involved in cell fate determination and patterning (37) (38) (39) (40) (41) and integrin signaling (17) . Notch is expressed in all layers of the epidermis and has been suggested to have a role in stem cell fate and maintenance in epidermis (15) and hair follicles (42, 43) . The potential importance of the Notch pathway is emphasized by the expression of the fringe genes, modulators of Notch signaling, in specific patterns in epidermis (44) . Furin over-expression has been shown to inhibit differentiation in a-cells of pancreatic islets (45) and gastric mucosal cells (33) . In contrast inhibition of furin in epidermal organotypic cultures leads to premature differentiation of keratinocytes, possibly via its effects on the Notch pathway (Pearton et al., in preparation). Furin is not strongly expressed in the spinous layers, but is detectable in the granular layer with altered epitope accessibility correlated with detection of the 75 kDa form of the enzyme. In this layer furin, and other PCs, would have access to a different range of substrates including cytoplasmic proteins such as profilaggrin. Both furin and PACE4 are able to cleave profilaggrin in vitro to release a fragment of the size predicted by cleavage at the junction with the filaggrin domains (27) . PC5/6 and PC7/8 are also expressed in the epidermis but it is not known whether they have similar cleavage specificity towards the profilaggrin substrate.
Profilaggrin is a highly phosphorylated insoluble protein of keratohyalin. During terminal differentiation it is processed by phosphatases and proteases to release the amino-terminus and individual filaggrin domains which bind to and aggregate keratin filaments (46) . Although several enzymes involved in profilaggrin processing are known, the early events are not understood (reviewed in 31). The amino-terminus containing the S-100 Ca 2π -binding domain (A domain) and a cationic B domain moves to the nucleus in transition cells while the filaggrin domains remain in the cytoplasm (47) (27, 48) . A canonical PC cleavage motif (R 288 TRKRR 293 ) lies at the junction between the B domain and the first filaggrin repeat. This site is very different from the hydrophobic cleavage motif (FLY in human) located between the filaggrin repeats (5, 49) which is the target of specific proteases such as PEP1 (5) . The domain-specific cleavage of profilaggrin in vitro (37 kDa product) is similar but not identical to that detected in vivo (approx. 32 kDa) (Figs 6, 7) . This difference could be due in part to the presence of the FLAG epitope which was required to enhance solubility of this test substrate. However, additional cleavages may also occur in vivo, and further study will be required to determine the involvement of PC in this processing pathway in vivo.
Nevertheless, cleavage of the profilaggrin amino-terminus is a critical event for altering the solubility of the protein for subsequent PEP1 cleavage of the filaggrin units (Resing et al., submitted), as well as for generating the S-100-like domain for nuclear translocation where it may have distinct functions in calcium-regulated events during terminal differentiation (47, 48, 50, 51) . The profilaggrin domain-specific processing, the furin localization and its change in accessibility during differentiation, and the calcium-dependent processing, all suggest a functional role for PCs in terminal differentiation in vivo. Our findings emphasize the pivotal role of proteases in processing profilaggrin and adds furin/PACE to the list of proteases (i.e. profilaggrin endoproteinase 1 (5), calpain (52), plasmin and chymotrypsin-like proteases (53) ) that are likely to have significant roles in terminal differentiation of epidermal cells.
In summary we present the first systematic analysis into the expression and localization of the PCs in epidermis. We have shown the localization of furin and PC7/8 using immunofluorescence and present evidence that furin undergoes a change of accessibility between the basal and granular layers that is related to cleavage to a soluble form that would have access to different types of substrates in these two distinct sites. We show that inhibition of PCs in keratinocytes inhibits processing of Notch-1, a known substrate with implications for cell fate determination and patterning. We also demonstrate that PCs are able to specifically cleave the amino-terminus of profilaggrin, a novel substrate found in the granular layer of the epidermis. This work indicates that the PCs may play multiple roles during the differentiation of cells within the epidermis.
